Boston University at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
Boston University brings 8 presentations to IDWeek 2026 in Washington. Its program centres on tuberculosis and hepatitis C, from diagnosis and nutrition to access to treatment. Concrete topics include how common undernutrition is among people newly diagnosed with tuberculosis and prior authorization rules that restrict access to curative hepatitis C drugs.
| Organization | IDWeek 2026 Attendance |
|---|---|
Boston University Boston, MA | |
Poster Fri Oct 23 12:15pm–1:30pm Safety of diagnostic methods for cervical TB lymphadenitis: A systematic review Poster Fri Oct 23 12:15pm–1:30pm Undernutrition Is Highly Prevalent among Newly Diagnosed People with Tuberculosis: A Systematic Review and Meta-analysis Poster Fri Oct 23 12:15pm–1:30pm What makes a tuberculosis relapse-risk biomarker cost-effective? A modeling study of biomarker-guided treatment extension in India Poster Sat Oct 24 12:15pm–1:30pm Hospitalization as an Opportunity for Hepatitis C Treatment: Care Patterns Prior to a Medications-at-Discharge Program Poster Sat Oct 24 12:15pm–1:30pm Impact of Inpatient SARS-CoV-2 Virus Testing Policy on Healthcare-Associated Respiratory Virus Transmission across the VA Healthcare System Poster Sat Oct 24 12:15pm–1:30pm Impact of the 2023 CDC Hepatitis C Perinatal Screening Recommendations: An Interrupted Time Series Analysis Poster Sat Oct 24 12:15pm–1:30pm Substance Use Treatment and Practices among People with Serious Injection-Related Infections: Baseline Data from a Pilot Randomized Controlled Trial Talk Sat Oct 24 3:45pm–4:00pm Prior Authorization Requirements Restricting Access to Curative Hepatitis C Medications in US Medicaid and Commercial Insurance Plans HIV, sexually transmitted infections and viral hepatitisAntimicrobials, resistance and stewardship |
Instantly find 20 buyers from Boston University
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction